Home > Press > Picosun posts third consecutive positive result
Abstract:
Today, marking the opening of the 9th International Conference on Atomic Layer Deposition in Monterey, California, Picosun Oy, Finland-based global manufacturer of state-of-the-art Atomic Layer Deposition (ALD) systems, preliminarily announced posting its third consecutive positive annual result.
Picosun's year-on-year revenues rose by a healthy 22 percent, and the company posted a small profit. "Given the overall state of the global economy, this is all the more significant, because during the fiscal year of May 1st 2008 to April 30th 2009 Picosun invested heavily into its new laboratory, R&D and production facilities in Kirkkonummi, Finland", says Kustaa Poutiainen, Chief Executive Officer of Picosun.
Thus far, the Picosun saga has been one of exceptional qualities. Founded as recently as 2004, the company has developed itself through organic growth, building an impressive portfolio of ALD systems both for research and production use. Whilst most high-tech start-ups seem to compete with accumulated losses, Picosun is maintaining its profitability throughout the economic crisis.
"We are getting completely ready for the big leap", Poutiainen smiles."Because of our organic growth policy, however, we are not in a hurry."
Global recession has not been felt too much at Picosun. "We get conflicting signs from different parts of the world, but for a global player like ourselves, the sum total seems to be rather even keeled, tilting towards sustained growth," explains Kustaa Poutiainen.
Geographically, the latest sales of Picosun's systems, research and company clients, have gone to countries very much affected by the global gloom. "This only proofs the axiom that even in the midst of the murkiness of the global downturn, the most forward looking, most clear headed players always make sure to be on top of technology when the upsurge starts. To be absolutely certain, they come to us. Picosun represents the brightest of the latest in its own field of technology and clearly benefit from its unique position," Poutiainen says.
The 9th International Conference on Atomic Layer Deposition (ALD 2009) is a three-day meeting 20 to 22 July (preceded on the 19th of July by one day of tutorials), dedicated to the science and technology of atomic layer deposition of thin films. Picosun exhibits its customer-praised line of ALD systems at the venue of the ALD 2009 conference, Portola Hotel and Spa in Monterey, California at the exhibition area.
####
About Picosun Oy
Picosun develops and manufactures Atomic Layer Deposition (ALD) reactors for micro- and nanotechnology applications. Picosun represents continuity to over three decades of ALD reactor manufacturing in Finland. Picosun is based in Espoo, Finland and has its US headquarters in Detroit, Michigan. SUNALE™ ALD process tools are installed in various universities, research institutes and companies across Europe, USA and Asia.
Dr. Tuomo Suntola, inventor of ALD technology, is Member of the Board of Directors of Picosun. World’s most experienced ALD reactor designer Sven Lindfors is Picosun’s Chief Technology Officer and one of the founders of the company. Picosun Oy is a part of Stephen Industries Inc Oy.
For more information, please click here
Contacts:
Pekka Reinikainen
Phone: +358407479312
Picosun Oy
Mr. Juhana Kostamo
Managing Director
Tietotie 3
FI-02150 Espoo, Finland
Tel. +358 50 321 1955
Fax. +358 20 722 7012
e-mail: info (at) picosun.com
Copyright © Picosun Oy
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||